Strategic Account Manager (UK)

England, United Kingdom

Auto‑apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

AI & Machine Learning, Consumer SoftwareIndustries

Requirements

Candidates should have a proven track record in account management, particularly with large enterprise clients such as FTSE 100 and Fortune 500 companies. A strong understanding of AI solutions and SaaS products is essential, along with excellent communication and relationship-building skills. Experience in driving revenue growth and managing complex client relationships is required, and familiarity with the technology sector is preferred.

Responsibilities

The Strategic Account Manager will work closely with the CEO and other senior leaders to drive revenue growth and establish strong client relationships. They will manage a portfolio of large enterprise accounts, engaging with major brands to increase the adoption of Natter's technology. The role involves developing strategies to scale usage within large organizations and meeting ambitious revenue targets.

Skills

Account Management

Client Relationship Management

Revenue Growth

Strategic Account Management

Sales

FTSE 100

Fortune 500

Blue-chip brands

SaaS

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free